1039744-23-4 Usage
Uses
Used in Pharmaceutical Industry:
2-Bromo-4-fluoro-1-(methylsulfonyl)benzene is used as an intermediate in the production of pharmaceuticals for its ability to be incorporated into the molecular structures of various medicinal compounds, enhancing their therapeutic properties and effectiveness.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Bromo-4-fluoro-1-(methylsulfonyl)benzene serves as an intermediate in the synthesis of agrochemicals, contributing to the development of more effective pesticides and other agricultural products to protect crops and enhance yield.
Used in Organic Compounds Synthesis:
2-Bromo-4-fluoro-1-(methylsulfonyl)benzene is utilized in the synthesis of various organic compounds such as dyes and pigments, where its unique chemical properties allow for the creation of a wide range of colorants and other specialty chemicals for different industries.
Safety Precautions:
Given its classification as a hazardous substance, 2-Bromo-4-fluoro-1-(methylsulfonyl)benzene can cause irritation to the skin, eyes, and respiratory system upon contact or inhalation. Therefore, it is crucial to follow proper safety measures when handling and storing this chemical to mitigate potential health and environmental risks.
Check Digit Verification of cas no
The CAS Registry Mumber 1039744-23-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,9,7,4 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1039744-23:
(9*1)+(8*0)+(7*3)+(6*9)+(5*7)+(4*4)+(3*4)+(2*2)+(1*3)=154
154 % 10 = 4
So 1039744-23-4 is a valid CAS Registry Number.
1039744-23-4Relevant academic research and scientific papers
MORPHOLINO SUBSTITUTED UREA DERIVATIVES AS MTOR INHIBITORS
-
Page/Page column 58, (2011/10/03)
The invention relates to compounds of formula (I) wherein X1, X2, R1 to R4, m, n have the meaning as cited in the description and the claims. Said compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR related diseases and disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
BIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
-
Page/Page column 119, (2008/12/07)
Bipiperidinyl compounds of the formula I, are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
